New Brooke Response23 Mar 2023 14:03
I have received an interesting response to a question I sent to Synairgen.
This is the original question:
"Good morning,
There are questions on the LSE forum about the sources of the UNIVERSAL trial funding.
In the RNS dated 5 September 2022, it states that Janssen are the sole source of funding.
However, according to the ISRCTN registry, BOTH Janssen and AZ are providing funding for the trial:
https://www.isrctn.com/ISRCTN49183956
So, is it only Janssen OR both Janssen and AZ that are providing funding?"
I received the following response from Brooke:
"I can confirm, per our RNS in September 2022, Synairgen is providing viral testing equipment (already owned by Synairgen) and nursing staff at the Southampton clinical trial site. As we are not the sponsors of this trial, it is not for me to comment on other funders that Southampton may have involved. I suggest this is a question for the clinical trials unit at the University."